PD-1 was widely recognized as an inhibitory marker on CD8 and CD4 T cells in chronic viral infections in humans, such as chronic HIV, HBV, and HCV infections (Fenwick et al., 2019; Zhou et al., 2023). This evidence concerns the gene CD8A and viral infectious disease.